Patients with cutaneous T-cell lymphoma may experience different stages of the disease, including itchy rashes or raised patches on the skin, tumors, ulceration, exfoliation or spreading to the lymph nodes or internal organs. Penn’s dermatologists offer state-of-the-art treatments for both early and late stage cutaneous T-cell lymphoma. Treatment options may include:
Photopheresis is a treatment in which white blood cells are collected, then treated with a medication that is activated by ultraviolet light, acting as a "vaccination" against disease-producing T-cells.
The Penn Dermatology Phototherapy Treatment Center offers patients a broad range of ultraviolet light services and individual treatment programs, education and counseling.